Femme et Homme | 18 ans et plus
- | Pays :
- France
- | Organes :
- Sein
- | Spécialités :
- Hormonothérapie
Extrait
EMERALD - RAD1901-308 - Elacestrant monotherapy vs. Standard of care for the treatment of patients with ER+/HER2- advanced breast cancer following CDK4/6 inhibitor therapy: a phase 3 randomized open-label, active-controlled, multicenter trial